Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

Takeda: Stainless steel COVID vaccine contamination due to human error

October 1, 2021 Medical Communications

Takeda has said that “human error” led to metal contaminants being present in Moderna’s COVID-19 vaccine doses, which caused around …
News

GSK and Merck KGaA end collaboration on cancer drug hopeful

October 1, 2021 Medical Communications

GSK and German based Merck KGaA announced on Thursday that they have ended their collaboration on cancer treatment bintrafusp alfa, …
News

Eisai launch bid for accelerated FDA approval for new Alzheimer’s drug

September 28, 2021 Manufacturing and Production, Medical Communications, Research and Development

Japanese drug maker Eisai has launched a bid for accelerated FDA approval for its new experimental drug for early Alzheimer’s …
News
sanofi_hq__boetie_hall_web

Sanofi drops mRNA COVID vaccine candidate amid success of rivals

September 28, 2021 Manufacturing and Production, Medical Communications

French healthcare group Sanofi has announced that it is dropping plans for its mRNA COVID vaccine due to the success …
News
nigel-tadyanehondo-god2mdnujuu-unsplash

Driver shortages: UK pharmacies left in dark by government

September 27, 2021 Business Services, Medical Communications, Sales and Marketing

Pharmacists in the UK have been left in the dark by the government, as they still don’t know what measures …
News

COVAX to revamp allocation system as smaller countries miss out on doses

September 27, 2021 Medical Communications, Sales and Marketing

COVAX is set to change its vaccine allocation methodology as it does not take into account a country’s vaccinated population, …
News

Theramex pioneers new treatment for post-menopausal women

September 24, 2021 Medical Communications

Theramex has recently launched the first and only body-identical hormone therapy treatment (HRT) for post-menopausal women, in the form of …
News

Eurazeo set to become leading investor in Kurma Partners

September 24, 2021 Medical Communications

Eurazeo has announced its intention to raise its stake in Kurma Partners, a French venture capital firm specialising in biotechnology …
News

AstraZeneca and MSD’s Lynparza shows potential for prostate cancer patients

September 24, 2021 Medical Communications

The PROpel Phase III trial has shown that Lynparza (olaparib) in combination with abiraterone demonstrated a significant improvement in radiographic …
News
az

AstraZeneca and VaxEquity to collaborate on saRNA platform

September 24, 2021 Medical Communications

AstraZeneca and VaxEquity have announced a collaboration to progress VaxEquity’s platform technology through proof of concept to enable the development …
News

CGT Catapult and Quell Therapeutics enter manufacturing collaboration

September 24, 2021 Medical Communications

CGT Catapult and Quell Therapeutics have announced a collaboration to facilitate an expanded manufacturing footprint focusing on the manufacturing capacity …
News

Government report finds serious overprescription issues in England

September 22, 2021 Medical Communications, Research and Development

A government report has found serious overprescription issues in England, with 10% of items dispensed in primary care being overprescribed, …
News

J&J: Second COVID shot boosts effectiveness by 94%

September 22, 2021 Medical Communications, Research and Development

Johnson & Johnson have released data showing that a second dose of their one shot COVID-19 vaccine boosts protection from …
News

ONS data shows long COVID less common than feared

September 17, 2021 Medical Communications

New data released by the Office for National Statistics (ONS) reveal that only one in 40 people with coronavirus goes …
News

NICE recommends MSD’s Keytruda for oesophageal cancer patients

September 17, 2021 Medical Communications, Research and Development

NICE has approved the use of pembrolizumab – MSD’s checkpoint inhibitor immunotherapy – in combination with platinum- and fluoropyrimidine-based chemotherapy, …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026